The global Parkinson's disease therapeutics market, valued at US$5.92 billion in 2024, is projected to reach US$12.83 billion by 2033 at an 8.1% CAGR. Explore drivers like rising prevalence (10M+ worldwide, 90K new US cases yearly), gene therapies, and FDA approvals like ONAPGO amid aging populations and R&D funding. https://finance.yahoo.com/news/parkinsons-disease-therapeutics-market-size-143000110.html